glp-1 vs insulin Favorable Effects of Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine The role of GLP1 receptor

The Role of a Health Savings Account GLP-1 drugs are HSA-qualified because they fall within the description of "diagnose, cure, mitigate, prevent, or treat an injury, illness, or condition." Specifically, they treat patients with a diagnosis of obesity

Providers often use serial lab testing (IGF-1, growth hormone curves) and clinical assessments (subjective improvement in energy, body composition) to determine responsiveness

We outline the potential for multitarget therapy incorporating reninangiotensinaldosterone system inhibitors, sodiumglucose co-transporter-2 inhibitors, incretin-based treatments and nsMRAs to improve cardiovascular and kidney outcomes in patients with overweight/obesity and T2DM

Davies, V.R

Hair Growth & Follicular Health Recent investigations indicate that GHK-Cu: Activates dermal papilla cells, the specialized cells at the base of hair follicles controlling growth phase (anagen) entry Reduces follicle sensitivity to DHT (dihydrotestosterone), the hormone primarily responsible for androgenetic alopecia Promotes angiogenesis to the scalp, increasing oxygen and nutrient delivery to follicles Suppresses inflammatory cytokines that contribute to follicle miniaturization Enhances hair density and thickness through collagen synthesis and follicular cell proliferation Safety Considerations The safety profile is well documented

doi:10.1007/s00404-024-07849-9 Ivanisevic M, Herman M, Horvaticek M, Vucic Lovrencic M, Delmis J